Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or survival after a median five years of follow-up, according to results from the BOOG 2013-08 phase I... Read more
Medical News - Dec 11
The Global Image-Guided Biopsy Market was valued at US$ 1.4 billion in 2024 and is projected to reach US$ 2.05 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2025-2031). This growth is fueled by the Read more
Openpr.com - Nov 11
Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing (multi-cancer early detection testing) could substantially reduce late-stage cancer diagnoses, allowing patients to receive treatment at earlier cancer stages, which are more likely ... Read more
Medical Xpress - Nov 10
Hyundai Hope on Wheels has awarded nearly $2.8 million to support Dr. Steven Jonas’ research at UCLA. Read more
University Of California, Los Angeles - Aug 08
